Click image to enlarge
U-PLEX Combos offer popular panels of biomarkers that have been grouped together for convenient ordering. They have been tested for multiplex compatibility and are fulfilled as a kit. The U-PLEX Adipokine Combo 1 (mouse) combines assays for 8 traditional metabolic and inflammatory markers (Table 1). The assays can be used for quantitative measurements in the sample types listed in the "Specifications" tab below, and offer detection limits (LLODs) in the sub- to low pg/mL range.
Analyte | LLOD - ULOD | units |
BDNF | 0.72 - 2,000 | pg/mL |
IL-1β | 3.1 - 13,000 | pg/mL |
IL-6 | 4.8 - 16,000 | pg/mL |
IL-10 | 3.8 - 22,800 | pg/mL |
Insulin | 3.0 - 5,500 | μIU/mL |
Leptin | 11 - 50,000 | pg/mL |
MCP-1 | 1.4 - 1,400 | pg/mL |
TNF-α | 1.3 - 6,200 | pg/mL |
-
-
Specifications
-
Kit Contents
-
-
Documentation
-
References
Application(s)
|
|
Metabolic
|
|
Analyte(s)
|
|
BDNF, IL-1β, IL-6, IL-10, Insulin, Leptin, MCP-1, TNF-α
|
|
Species
|
|
Mouse
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO SECTOR S 600MM
|
|
U-PLEX Group Compatibility
|
|
Metabolic Group 1
|
|
Plate Type
|
|
96-well
|
|
Sample Type
|
|
Cell Culture Media, EDTA Plasma, P800 Plasma, Serum
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
U-PLEX Linker Set, 8-Assay (300 µL)
|
2-8 °C
|
1 each (1 vial)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 each (1 plate size)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
|
2-8 °C
|
1 vial (1 vial)
|
|
U-PLEX 8-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
1 each (1 plate)
|
|
U-PLEX Stop Solution
|
2-8 °C
|
1 bottle (40 mL)
|
|
|
≤-10 °C
|
1 bottle (10 mL)
|
|
|
≤-10 °C
|
1 bottle (10 mL)
|
|
|
RT
|
1 bottle (18 mL)
|
|
Aprotinin
|
2-8 °C
|
1 vial (50 μL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
U-PLEX Linker Set, 8-Assay (1.8 mL)
|
2-8 °C
|
1 each (1 vial)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
1 each (5 plate size)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
|
2-8 °C
|
5 vial (1 vial)
|
|
U-PLEX 8-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
5 each (1 plate)
|
|
U-PLEX Stop Solution
|
2-8 °C
|
1 bottle (40 mL)
|
|
|
≤-10 °C
|
1 bottle (50 mL)
|
|
|
≤-10 °C
|
1 bottle (50 mL)
|
|
|
RT
|
1 bottle (90 mL)
|
|
Aprotinin
|
2-8 °C
|
1 vial (250 μL)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
U-PLEX Linker Set, 8-Assay (1.8 mL)
|
2-8 °C
|
5 each (1 vial)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
5 each (5 plate size)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
|
2-8 °C
|
25 vial (1 vial)
|
|
U-PLEX 8-Assay, 96-Well SECTOR Plate
|
2-8 °C
|
25 each (1 plate)
|
|
U-PLEX Stop Solution
|
2-8 °C
|
5 bottle (40 mL)
|
|
|
≤-10 °C
|
5 bottle (50 mL)
|
|
|
≤-10 °C
|
5 bottle (50 mL)
|
|
|
RT
|
5 bottle (90 mL)
|
|
Aprotinin
|
2-8 °C
|
5 vial (250 μL)
|
|
Product Inserts
|
|
|
Datasheets
|
|
View More
|
Product Highlights
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops
|
|
|
|
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke
|
|
|
|
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
|
|
|
|
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
|
|
|
|
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
|
|
|
|
View All
|
Order Details
Catalog No
Size
Price in USD
Qty
Meso Scale Japan 株式会社